Anda di halaman 1dari 9

MARKET RESEARCH

PHILIPPINES
Country Introduction
The Philippine health sector is a pubic-private mixed system, with the private
sector dominating the market.

The annual GDP growth rate is 0.92%4

The GDP per capita was US$ 1,744.63 (at the current exchange rate ).

Non-communicable diseases steadily increased while communicable


diseases diminished in scale.
59% of total health financing came from private sources vi .
However, the public sector plays a significant role in the provision, financing,
as well as regulation of health services.

Private sector =better quality, but are also more expensive.


Value World Rank
POPULATION TOTAL 102,624,209 13
SEX RATIO M / F 1.01 44
POPULATION 0-14 33.7 % 55
POPULATION 15-64 61.9 % 136
POPULATION 65 + 4.4 % 120
BIRTH RATE / 1000 24.00 57
DEATH RATE / 1000 6.10 136
FERTILITY RATE 3.06 53
INFANT MORTALITY 21.90 77
SEX RATIO AT BIRTH M / F 1.05 58
SEX RATIO UNDER 15 M / F 1.04 94
SEX RATIO 15-64 M / F 1.02 66
SEX RATIO 65 + M / F 0.72 137
NET MIGRATION -2.00 144
POPULATION GROWTH 1.59 % 65
LITERACY TOTAL 95.4 % 78
LITERACY MALE 95.8 % 68
LITERACY FEMALE 96.8 % 44
UNEMPLOYMENT 6.3 % 114
LIFE EXPECTANCY / BIRTH 68.5 124
HEALTHY LIFE EXPECTANCY 61.1 122
GDP PER CAPITA USD $7,500 122
Disease Profile (Inpatient care)
Acute respiratory infection
ALTRI and pneumonia
Bronchitis/bronchiolitis
Hypertension
Acute watery diarrhea
Influenza
TB respiratory
Acute febrile illness
Diseases of the heart
Chickenpox
* Leading causes of morbidity for inpatient care
Disease
Heart diseases
Vascular system diseases
Malignant neoplasm
Pneumonia
Road traffic accidents
Tuberculosis, all forms
Chronic lower respiratory diseases
Diabetes Mellitus
Certain conditions originating in the perinatal period
Nephritis, nephrotic syndrome and nephrosis

*Diseases of the heart and vascular system are the leading


causes of mortality, comprising nearly one-third (31%) of all
deaths.
Medications provided publicly, at no cost

Malaria =Yes
Tuberculosis =Yes
Sexually transmitted diseases =No
HIV/AIDS =Yes
Expanded Program on Immunization (EPI) vaccines for children =Yes
For inpatients only + DOH vertical programmed (malaria, tuberculosis,
HIV/AIDS)
GPL Fit
Hypertension drugs

Diabetics drugs

Respiratory drugs

Antibiotics

Painkiller
Manufacturing
61 licensed pharmaceutical manufacturers in the Philippines.

Manufacturing capabilities

Research and Development for discovering new active substances = No


Production of pharmaceutical starting materials (APIs) = No
The production of formulations from pharmaceutical starting material = Yes
The repackaging of finished dosage forms = Y
What segment-growth of last 3 yrs

Diseases of the heart and vascular system are the


leading causes of mortality, comprising nearly one-
third (31%) of all deaths

Therefore cardiovascular drugs the segment that increases.

Anda mungkin juga menyukai